Bupropion + Escitalopram + Venlafaxine + SERTRALINE for schizophrenia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Nov 2022: Trial registered, NCT05603104
  2. 27 Apr 2025: Trial started, NCT05603104
  3. 24 Jun 2026: Trial terminated, NCT05603104

The trials

NCT05603104: Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

State
Stopped early
Phase
Phase 3
People
1 taking part
Started
27 Apr 2025
Primary completion
24 Jun 2026
Arms
Bipolar Depression EIPT: Switch to one of the following combinations:
Results
None posted
  1. 2 Nov 2022: Trial registered
  2. 27 Apr 2025: Trial started
  3. 24 Jun 2026: Trial terminated

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.